To explore the physiological role of METTL3 O-GlcNAcylation in vivo, we established an HCC mouse model by high-volume tail vein injection of plasmids containing SB100, AKT, and NRASV12 (Fig. 7H). The gene discussed is AKT1; the disease is hepatocellular carcinoma.